3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
43
Liver Neoplasms
14
Colorectal Neoplasms
11
Recurrence
6
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Pancreatic Neoplasms
3
Colonic Neoplasms
3
Rupture, Spontaneous
2
Stomach Neoplasms
1
Sarcopenia
1
Reperfusion Injury
1
Postoperative Complications
1
Obesity, Morbid
1
Metabolic Syndrome
1
Liver Failure
1
Klatskin Tumor
1
Ischemia
1
Hypertension, Portal
1
Focal Nodular Hyperplasia
1
Fibrosis
1
Disseminated Pancreatic Cancer
1
Disease Progression
1
Conversion Disorder
1
Colorectal Cancer Metastatic
1
Cirrhosis, Familial, with Pulmonary Hypertension
1
Carcinoma
1
Abdominal Injuries
1
Interventions
Gemcitabine
6
Cisplatin
6
Capecitabine
6
Liver Transplantation
4
Fluorouracil
4
Specimen Handling
3
Radiosurgery
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
toripalimab
2
dehydroftorafur
2
Self Expandable Metallic Stents
2
Platinum
2
Leucovorin
2
Biopsy
2
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
2
1,2-diaminocyclohexaneplatinum II citrate
2
trisacryl gelatin microspheres
1
tremelimumab
1
trametinib
1
tislelizumab
1
temoporfin
1
sacituzumab govitecan
1
ricolinostat
1
pembrolizumab
1
lenvatinib
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
durvalumab
1
binimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
Hepatectomy
×
Gastrointestinal
×
Clear all
NCT02232932
2021-11-03
TRANSPHIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Unknown
60 enrolled